The United States Patent and Trademark Office has issued the following patents to NeuroRepair, Inc.:


US Patents Pending
Working with protein engineering firm BioAtla, LLC., NeuroRepair, Inc. has developed several new mutants of the already highly efficacious Transforming Growth Factor-alpha that may have some therapeutic attributes for neurological repair and regeneration that are superior to native TGFa.


US Patent #8,158,578 B2
Methods for treating neurological deficits


US Patent #8,138,143 B2
Methods for treating a neurological disorder by peripheral administration of a trophic factor


US Patent #7,790,669
Methods for Treating Neurological Deficits By Intrastriatal Administration of Transforming Growth Factor Alpha


US Patent #7,795,202
Methods for Treating a Neurological Disorder By Peripheral Administration of Transforming Growth Factor Alpha Issued 9/14/10.


7 Top Medical Breakthroughs Just Around the Corner
NewsMax cover story, November 2011. Interview with James Fallon, Ph.D.


NeuroRepair Validates IP with Lab’s Success in New Stroke Therapy
Two recent studies by neuroscientists at the University of California, Irvine, have had startling success with a neuroregenerative therapy tested in rats.


Breakthrough Stroke Drug Could Almost Completely Reverse Limb Paralysis
Fox News Posts Health Headline and Article on James Fallon’s recent studies.


Drug to Spur New Cells, And Without the Politics

New York Times

“James H. Fallon of the University of California at Irvine reported that a protein called transforming growth factor alpha stimulated the stem cells in the brains rates to proliferate and migrate to the site of injuries similar to those caused by Parkinson’s…and repaired some of the damage.”


Intranasal Administration of PEGylated Transforming Growth Factor-α Improves Behavioral Deficits in a Chronic Stroke Model

Ependymal Stem Cells Divide Asymmetrically and Transfer Progeny Into the Subventricular Zone When Activated by Injury

Transforming Growth Factor-Alpha Induces Neurogenesis and Behavioral Improvement in a Chronic Stroke Model

Rebuilding the Nervous System with Stem Cells
Chapter 8 of the report, Stem Cells: Scientific Progress and Future Research DirectionsJune 17, 2001, The National Institutes of Health resource for stem cell research

In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain

Repairing Brains, by Matthew Klipstein

NeuroRepair was named by Mark Anderson as a “Firestarter Company” and “Outstanding Company of the Conference” at the 2010 FiRe Conference.

“We believe that these FiReStarter businesses, which are integrated into the FiRe program, are on the cusp of making great strides in improving our world. They are businesses we believe you should know about.”

Mark Anderson, Future in Review [FiRe] Conference

Hosted by Mark Anderson, founder and publisher of the Strategic News Service™, the Future in Review [FiRe] Conference exposes world experts and participants to new ideas in a manner that produces an accurate portrait of the future in technology, including the global economy, cloud computing, biology and medical diagnostics, policy, netbooks, space travel, sustainability, and other fields that contribute to technology outcomes.